Moreover, in IL-1α-stimulated primary human KCs, the mRNA expression of IL-8 and TNF-α is reduced in a dose-dependent fashion in presence of the novel and selective PDE4 inhibitor DRM02 [283]. The gene discussed is PDE4A; the disease is dry eye syndrome.